Navigation Links
Progen Announces PI-88 Phase 2 Lung Cancer Results
Date:9/24/2007

BRISBANE, Sept. 24 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced that the Phase 2 trial administering 250mg of PI-88 in combination with the chemotherapeutic agent docetaxel to patients with advanced non small cell lung cancer did not meet its primary endpoint of significantly improving the progression-free rate at six months compared to docetaxel alone. The trial also did not meet its secondary endpoints of improvement in time to progression, response rate, overall survival and quality of life measures.

The overall data from this trial suggests that no further investigation of PI-88 in combination with docetaxel in patients with non small cell lung cancer that have failed platinum based first line therapies is warranted. However, nine patients in the study switched to PI-88 after experiencing toxicity or disease progression with docetaxel monotherapy. The data for this patient group suggests a potential survival benefit that Progen intends to investigate further with, amongst others, the clinicians involved in this study.

"We are disappointed, first and foremost, for the patients with non small cell lung cancer that have disease progression following platinum based chemotherapy as treatment options are limited," said Justus Homburg, Progen's Chief Executive Officer. "The outcome of this study has no impact on our Phase 3 registration strategy for patients with post-resection liver cancer which we announced today has been granted fast-track status designation by the U.S. FDA."

"It is quite common for new drugs to show benefit in one patient group but limited benefit in another. To date, PI-88 has shown evidence of benefit in patients with melanoma, multiple myeloma and post-resection liver cancer. In particular, PI-88 may be more active for tumors that are at an earlier disease stage, such as has been demonstrated in the PI-88 Phase 2 primary liver cancer trial" added Homburg. "In that tria
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
3. Progens Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NUEVA YORK , 22 de mayo ... (NASDAQ: DPRX ), una compañía farmacéutica ... y comercialización de Locilex® (pexiganan cream 0.8%), ... hoy una presentación de póster destacando el ... fase 3 de la Compañía que evalúan ...
(Date:5/22/2015)... May 22, 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues ("BioLife" or the "Company"), announced that the Company ... The Company is scheduled to present at ... 2015 at the Grand Hyatt Hotel in New ...
(Date:5/22/2015)... 2015 The leading companies in the ... cardiac rhythm management device market dominate their competition, ... St. Jude Medical, Boston Scientific and Asahi Kasei ... segment. The healthcare market research publisher,s report, ... as a base year, providing forecasts for each ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
(Date:5/24/2015)... May 24, 2015 ProPin is a ... Cut Pro X. Utilize ProPin to pin point locations on ... scene. , ProPin allows users to choose from 30 ... FCPX. With on-screen controls, video editors can easily manipulate ProPin ... pin and mark with absolute ease. , Using ProPin is easy, ...
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Jay Krihak as its head of programmatic strategy ... its expertise and leadership position in the data ... sectors. , Krihak is an experienced, award-winning agency ... led sales planning teams for mobile platform Jumptap. ...
(Date:5/24/2015)... 24, 2015 A report out ... the single best option for avoiding cardiovascular disease is ... level was the single most powerful predictor of death ... as diabetes and family history of premature death -- ... heart and lung fitness. , The Importance of Cardiovascular ...
(Date:5/23/2015)... Washington, D.C. (PRWEB) May 23, 2015 ... demonstration of powers of a youngster's yogic power learned ... by Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, ... of more than 50 high profile professionals attending the ... D.C. by reading fluently -- blindfolded. , In ...
(Date:5/23/2015)... May 23, 2015 With the implementation ... are finding it increasingly difficult to provide their employees ... to provide adequate insurance for employees stand to face ... such an integral part of a business’s success or ... for businesses, Online USA Doctors has created a varying ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3
... biologists have published a paper on how cells make specific ... learning more about human developmental disorders -- in the Aug. ... Academy of Sciences . Dietmar Schreiner, postdoctoral researcher, and ... College of Liberal Arts and Sciences Department of Biology, write ...
... impossible to achieve because some body areas are much more ... Researchers - funded by the Medical Research Council (MRC) - ... some holidaymakers find it so hard to achieve an even ... the journal Experimental Dermatology , show that the buttock ...
... Epidemiology Center at Boston University School of Medicine (BUSM) ... contraceptives have a greater likelihood of developing breast cancer ... in Cancer Epidemiology Biomarkers and Prevention , were ... (BWHS), a large follow-up study of 59,000 African American ...
... impact on the food you eat, the clothes you wear, ... a special section on Culture and Psychology in Perspectives ... Psychological Science, psychological scientists Denise C. Park from the University ... of Illinois at Urbana-Champaign discuss ways in which brain structure ...
... August 3, 2010 -- As the acute phase of ... marked by long-term challenges to the public health, environment ... Disaster Preparedness interviewed over 1,200 adults living within 10 ... in collaboration with the Children,s Health Fund and The ...
... (ASP) has announced the ninth class of T. Franklin ... previous T. Franklin Williams Scholars in working to achieve ... medicine subspecialists to care for the aging population. ... development awards funded by generous grants from the Atlantic ...
Cached Medicine News:Health News:U. Iowa biologists publish findings on cell interactions 2Health News:All-over tan is a myth, study finds 2Health News:Oral contraceptive use associated with increased risk of breast cancer 2Health News:Culture wires the brain: A cognitive neuroscience perspective 2Health News:Survey of coastal residents shows Gulf oil spill has significant impact on families 2Health News:Survey of coastal residents shows Gulf oil spill has significant impact on families 3Health News:ASP announces 2010 T. Franklin Williams Scholars 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: